
- Telehealth Visits
- Insurances Accepted

Jessica De Deleon, MD
Neurology • Neurology (Behavioral Neurology)- Telehealth Visits
- Insurances Accepted



Jessica De Deleon, MD
Neurology • Neurology (Behavioral Neurology)- Telehealth Visits
- Insurances Accepted
On this page
About me
Dr. Jessica De Leon is a neurologist who cares for patients with cognitive disorders. She has expertise in evaluating and treating symptoms in primary progressive aphasia (in which language capabilities become increasingly impaired), Alzheimer's disease and frontotemporal dementia (a group of degenerative diseases that gradually damage or shrink certain lobes of the brain).
With a five-year grant from the National Institutes of Health, De Leon is studying how bilingualism, language background and genetics affect the symptoms of neurodegenerative disorders, using primary progressive aphasia as a disease model.
After earning a bachelor's degree in neuroscience and Spanish at Johns Hopkins University, De Leon earned her medical degree at UCSF, where she also completed a residency in neurology and served as chief resident. She then completed a fellowship in behavioral neurology at UCSF.
Education
Board Certification
- Neurology, American Board of Neurological Surgery
Fellowship
- Behavioral Neurology, University of CA at San Francisco - Neurology GME
Residency
- Neurology, UCSF Medical Center House Staff
Internship
- Neurology, UCSF Medical Center House Staff
School
- MD, UCSF School of Medicine
Academic Title
- Professor-in-Residence
Care Keywords
Services
- Neurology
- Neurology (Behavioral Neurology)
Locations
Provider Research Listing
Browse clinical trials and publications by this provider
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.